The World Health Organisation has welcomed preliminary results of a drugs trial conducted by scientists in the UK, which shows a widely available, low-cost steroid can treat severely ill Covid-19 patients. Katherine Millbank, a British Covid-19 survivor, is among the 2,100 participants who took part in the clinical trial launched in March 2020.